AgrawalNFrederickMJPickeringCRBettegowdaCChangKLiRJFakhryCXieTXZhangJWangJ. et al. 2011. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 333(6046):1154–1157.
2.
AbalkhailKAKukuruzinskaMA. 2018. Emerging insights into Wnt/β-catenin signaling in head and neck cancer. J Dent Res. 97(6):665–673.
3.
ArgyrisPPSlamaZMRossKFKhammanivongAHerzbergMC. 2018. Calprotectin and the initiation and progression of head and neck cancer. J Dent Res. 97(6):674–682.
4.
GillisonMLKochWMCaponeRBSpaffordMWestraWHWuLZahurakMLDanielRWViglioneMSymerDE. et al. 2000. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 92(9):709–720.
5.
FukusumiTCalifanoJ.2018. The NOTCH pathway in head and neck squamous cell carcinoma. J Dent Res. 97(6):645–653.
6.
KemmerJDJohnsonDEGrandisJR. 2018. Leveraging genomics for head and neck cancer treatment. J Dent Res. 97(6):603–613.
7.
LindemannATakahashiHPatelAAOsmanAAMyersJN. 2018. Targeting the DNA damage response in OSCC with TP53 mutations. J Dent Res. 97(6):635–644.
8.
LuoJJYoungCDZhouHMWangXJ. 2018. Mouse models for studying oral cancer: impact in the era of cancer immunotherapy. J Dent Res. 97(6):683–690.
9.
MoskovitzJMFerrisRL. 2018. Tumor immunology and immunotherapy for head and neck squamous cell carcinoma. J Dent Res. 97(6):622–626.
10.
NonakaTWongDTW. 2018. Liquid biopsy in head and neck cancer: promises and challenges. J Dent Res. 97(6):701–708.
PickeringCRZhouJHLeeJJDrummondJAPengSASaadeRETsaiKYCurryJLTetzlaffMTLaiSY. et al. 2014. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res. 20(24):6582–6592.
13.
PinattiLMWallineHMCareyTE. 2018. Human papillomavirus genome integration and head and neck cancer. J Dent Res. 97(6):691–700.
14.
PolveriniPJD’SilvaNJLeiYL. 2018. Precision therapy of head and neck squamous cell carcinoma. J Dent Res. 97(6):614–621.
15.
ShangWZhangQHuangYShantiRAlawiFLeAJiangC.2018. Cellular plasticity -targeted therapy in head and neck cancers. J Dent Res. 97(6):654–664.
16.
StranskyNEgloffAMTwardADKosticADCibulskisKSivachenkoAKryukovGVLawrenceMSSougnezCMcKennaA. et al. 2011. The mutational landscape of head and neck squamous cell carcinoma. Science. 333(6046):1157–1160.
17.
TanYSSansanaphongprichaKPrinceMEPSunDWolfGTLeiYL. 2018. Engineering vaccines to reprogram immunity against head and neck cancer. J Dent Res. 97(6):627–634.
18.
The Cancer Genome Atlas Network. 2015. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 517(7536):576–582.
19.
WordenFPKumarBLeeJSWolfGTCordellKGTaylorJMUrbaSGEisbruchATeknosTNChepehaDB. et al. 2008. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol. 26(19):3138–3146.
